Copenhagen, Denmark · Founded 2018 · Privately Held (backing)
Developer of cannabinoids and psilocybin derivatives intended to improve the health and well-being of people. Octarine Bio is based in Copenhagen, Denmark and was founded in 2018. Its last reported valuation was $30.8 million in Jan 2026. It has raised $16.8 million.
Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$16.8M
Last round
—
Team — not yet on record
No current team members for Octarine Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Octarine Bio with a free account
·The complete investor list: 16 names
·Watch Octarine Bio: the Monday email on marks, rounds and moves
